233 related articles for article (PubMed ID: 8551474)
1. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
[TBL] [Abstract][Full Text] [Related]
2. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
3. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
4. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
[TBL] [Abstract][Full Text] [Related]
5. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine insemination results in couples requiring extended semen transport time.
Randall GW; Gantt PA
Int J Fertil Womens Med; 2007; 52(1):28-34. PubMed ID: 17987885
[TBL] [Abstract][Full Text] [Related]
8. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
12. The importance of the FSH/LH ratio in ovarian stimulation therapy regime for in vitro fertilization.
Bhat AM; Feichtinger W; Kemeter P
Acta Eur Fertil; 1984; 15(6):449-53. PubMed ID: 6443053
[TBL] [Abstract][Full Text] [Related]
13. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
16. Ovarian response and pregnancy outcome related to midfollicular LH levels in down-regulated women undergoing assisted reproduction.
Ferrari B; Barusi L; Lanna M; Coppola F
J Reprod Med; 2004 Mar; 49(3):148-52. PubMed ID: 15098883
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
20. Comparison of various therapies for the luteinized unruptured follicle syndrome.
Check JH; Dietterich C; Nowroozi K; Wu CH
Int J Fertil; 1992; 37(1):33-40. PubMed ID: 1348733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
